• Editor-in-Chief：ZHAO Yun
  ISSN：1674-7666
  CN：31-2035/Q
  Vol.47 No.3 (Mar. 2025)
• A Key Magazine of China Technology
  A Core Journal in Chinese Science Citation Database (CSCD)
  A Journal Included in the Chemical Abstracts (CA)
  A Journal Included in Japan Science and Technology Agency (JST)

NOVEL MECHANISMS OF TUMOR PATHOGENESIS

The Advances of Genetic Susceptibility to Nasopharyngeal Carcinoma
[316-328]

Research Progress on Nasopharyngeal Carcinoma Screening
[329-335]

The Diagnostic and Therapeutic Values of EBV DNA in Nasopharyngeal Carcinoma

[336-344]

The Mechanisms of EBV Infection and Carcinogenesis, and Strategies for Prevention and Treatment


[345-352]

Research Progress on Intratumoral Microbiota, Tumor Progression and Relevant Antitumor Strategies

[353-368]

Research Progress on Differentiation Therapy in Solid Tumors
[369-378]

RNA Methylation and Chromatin Remodeling in Cancer

[379-392]

The Role and Clinical Significance of Novel Pathways in Extracellular Vesicle Biogenesis in Cancer Progression

[393-402]

Advances in the Innate Immune Recognition of Nucleic Acids
[403-411]

Recent Advances in the Mechanisms and Prevention Strategies of Esophageal Cancer Metastasis
[412-431]

CUTTING-EDGE TECHNOLOGIES IN TUMOR DIAGNOSIS AND TREATMENT

Recent Advances in SERS (Surface-Enhanced Raman Scattering) for Deep-Tissue In Vivo Cancer Imaging
[433-449]

Artificial Intelligence and Big Data Technology Innovations Supporting Precision Diagnosis and Treatment of Cancers
[450-464]

Mitochondrial Fusion and Tumor Immunity
[465-474]

Neoantigen Vaccines and Immunotherapy: a Precision Approach for Hepatocellular Carcinoma Treatment
[475-485]

The Development of Humanized Mouse Models and Their Applications in Hematological Research
[486-495]

Advances in Single-Cell Sequencing Technology in Human Embryo Immune System Development
[496-511]

Targeting on the Tumor Stiffness: from Bench to Bed
[512-533]

Dissecting Early-Stage Tumor Microenvironment with Niche-Labeling
[534-540]

RESEARCH ON NOVEL TARGETS AND DRUGS FOR TUMOR THERAPY

DNA Damage Response and Its Inhibitors: Current Perspectives and Future Directions
[542-559]

IDH2 Mediated Metabolic Reprogramming and Targeted Drug Development
[560-569]

Study on the Pathogenesis of RNA Splicing Complex Mutation in Myelodysplastic Syndrome
[570-580]

Aberrant Regulation and Targeting of RNA Modifications in Acute Myeloid Leukemia
[581-597]

Research Progress of Cellular Stress in Colorectal Cancer
[598-610]

Study of Vasculogenic Mimicry in Glioma
[611-618]

Genetic and Epigenetic Regulation of Drug Resistance in Tumor Therapy
[619-631]

Regulatory Mechanisms of Tumor Cell Death and Targeted Interventions
[632-645]

New Mechanisms and Intervention Strategies to Overcome Drug Resistance in Cancer
[646-660]

Research Progress and Clinical Application Potential of Novel Small Molecule Inhibitors Targeting Apoptosis
[661-678]

PROGRESS IN THE PRECISE TREATMENT OF TUMOR

The Progress of Pathological Features in EBV-Associated Intrahepatic Cholangiocarcinoma
[680-685]

SYSUCC Study on Delaying and Overcoming Drug Resistance in EGFR Gene Mutation-Positive Lung Cancer
[686-691]

Mechanistic Insights into Resistance to Conversion Therapy in Hepatocellular Carcinoma
[692-701]

Research Progress on Clinical Diagnosis, Treatment, and Drug Resistance Mechanisms of T-Cell Lymphoma
[702-716]

Advance in Precision Prevention and Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
[717-729]

Research Progress of TCR-T Cells for the Treatment of Solid Tumors
[730-741]

Enhancing Efficacy and Reducing Toxicity: Therapeutic Optimization in Locoregionally Advanced Nasopharyngeal Carcinoma
[742-756]